Since the onset of the COVID-19 pandemic, there have been rare reports of spinal cord pathology diagnosed as inflammatory myelopathy and suspected spinal cord ischemia after SARS-CoV-2 infection. Herein, we report five cases of clinical myelopathy and myeloradiculopathy in the setting of post-COVID-19 disease, which were all radiographically negative. Unlike prior reports which typically characterized hospitalized patients with severe COVID-19 disease and critical illness, these patients typically had asymptomatic or mild-moderate COVID-19 disease and lacked radiologic evidence of structural spinal cord abnormality. This case series highlights that COVID-19 associated myelopathy is not rare, requires a high degree of clinical suspicion as imaging markers may be negative, and raises several possible pathophysiologic mechanisms.
CITATION STYLE
Abrams, R. M. C., Safavi, F., Tuhrim, S., Navis, A., Steinberger, J., & Shin, S. C. (2021). MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis? Journal of NeuroVirology, 27(4), 650–655. https://doi.org/10.1007/s13365-021-00986-w
Mendeley helps you to discover research relevant for your work.